A mathematical model to guide antibiotic treatment strategies

BMC Medicine

Jean-Philippe Lavigne¹  Albert Sotto² 

[1] Institut National de la Santé et de la Recherche Médicale, U1047, Université Montpellier 1, UFR de Médecine 30908 Nîmes Cedex 08, France;Service des Maladies Infectieuses et Tropicales, CHU Caremeau, 30029 Nîmes Cedex 09, France

关键词: multidrug resistance;    mathematical models;    antibiotic resistance;   

Others  :  857373
DOI  :  10.1186/1741-7015-10-90

 received in 2012-07-02, accepted in 2012-08-13,  发布年份 2012

【 摘 要 】

Over the past few decades, the emergence of multidrug resistance (MDR) to antibiotics in bacteria has led to major difficulties in the management of infected patients. At present, there is a serious lack of development of new antibacterial agents. Mathematical models are one approach to understand how antibiotic usage patterns may be optimized. However, the classical approach to modeling the emergence of MDR relies on the simplifying assumption that resistance is acquired at a constant rate. In their model, Obolski and Hadany introduce the notion of horizontal gene transfer and stress-induced mutation, with antibiotics constituting an environmental stressor of particular relevance. Finally, from this complex mathematical model, the authors propose predictions for minimizing MDR in bacteria depending on strategies of antibiotic treatment.

Please see related article: http://www.biomedcentral.com/1741-7015/10/89 webcite

【 授权许可】

   
2012 Sotto and Lavigne; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Carlet J, Mainardi JL: Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin? Clin Microbiol Inf 2012, 18:1-3.
• [2]Obolski U, Hadany L: Implications of stress-induced genetic variation for mimizing multidrug resistance in bacteria. BMC Medicine, in press.
• [3]Bonten MJ, Weinstein RA: Antibiotic cycling in intensive care units: the value of organized chaos? Crit Care Med 2006, 34:549-551.
• [4]Kermack WO, McKendrick AG: A contribution to the mathematical theory of epidemics. Proc Roy Soc Lond 1927, A115:700-721.
• [5]Varhimo E, Savijoki K, Jefremoff H, Jalava J, Sukura A, Varmanen P: Ciprofloxacin induces mutagenesis to antibiotic resistance independent of UmuC in Streptococcus uberis. Environ Microbiol 2008, 10:2179-2183.
• [6]Alonso A, Campanario E, Martinez JL: Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 1999, 145:2857-2862.
• [7]Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP: Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumonia. Science 2006, 313:89-92.
• [8]Waldor MK, Beaber JW, Hochhut B: SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004, 427:72-74.
• [9]Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N'Doye B, Pittet D, Richtmann R, Seto WH, van der Meer JW, Voss A: Society's failure to protect a precious resource: antibiotics. Lancet 2011, 378:369-371.
• [10]Wecke T, Mascher T: Antibiotic research in the age of omics: from expression profiles to interspecies communication. J Antimicrob Chemother 2011, 66:2689-2704.
• [11]Chavali AK, D'Auria KM, Hewlett EL, Pearson RD, Papin JA: A metabolic network approach for the identification and prioritization of antimicrobial drug targets. Trends Microbiol 2012, 20:113-123.
• [12]Huang JX, Bishop-Hurley SL, Cooper MA: Development of anti-infectives using phage display: biological agents against bacteria, viruses and parasites. Antimicrob Ag Chemother, in press.
• [13]Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, Coffey A, Ross RP, Hill C: Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio 2012, 3:e00029-12.
• [14]Seale A, Finn A: What is the best way to use conjugate vaccines? Curr Opin Infect Dis 2011, 24:219-24.
• [15]Morrow LE, Gogineni V, Malesker MA: Probiotic, prebiotic, and synbiotic use in critically ill patients. Curr Opin Crit Care 2012, 18:186-191.
• [16]Baron C: Antivirulence drugs to target bacterial secretion systems. Curr Opin Microbiol 2010, 13:100-105.
• [17]Sotto A, Richard JL, Messad N, Molinari N, Jourdan N, Schuldiner S, Sultan A, Carrière C, Canivet B, Landraud L, Lina G, Lavigne JP: Distinguishing colonization from infection with Staphylococcus aureus in diabetic foot ulcers with miniaturized oligonucleotide arrays: a French multicenter study. Diabetes Care 2012, 35:617-623.